4//SEC Filing
Tardio Jason 4
Accession 0001209191-22-007314
CIK 0001636651other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 6:24 PM ET
Size
5.4 KB
Accession
0001209191-22-007314
Insider Transaction Report
Form 4
Tardio Jason
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-03+175,000→ 175,000 totalExercise: $2.72Exp: 2032-02-02→ Common Stock (175,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the Stock Option will vest and become exercisable on February 3, 2023 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date.
Documents
Issuer
Ovid Therapeutics Inc.
CIK 0001636651
Entity typeother
Related Parties
1- filerCIK 0001794698
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 6:24 PM ET
- Size
- 5.4 KB